Red Mosquito

Strat wrote:He should have just printed MAGA facemasks and everything would have been fine.

McParadigm wrote:It’s sort of like how you regularly write “the virus won,” as if the virus pulled some wildly different tactic here than in other countries and our disproportionate suffering is all down to the actions of the virus.

We couldn’t take the steps that all those successful countries took to contain it because too many Americans care about and believe whatever nonsense the president says. We couldn’t use the lag in cases to build up our capacity because the president is at the center of federal pandemic response planning. Whether you have any interest in the cause and effect of the president of the United States advancing conspiracies about COVID is irrelevant to whether or not it matters.

elliseamos wrote:Chuck Woolery is a great doctor and scientist, McP.

verb_to_trust wrote:Does anybody even care what he says anymore? I'm going to go ahead and stay stone cold sober. Fuck Trump.

McParadigm wrote:

elliseamos wrote:Chuck Woolery is a great doctor and scientist, McP.

Pretty sure going by “Chuck” gets you an automatic rejection letter at most med schools

elliseamos wrote:
Needless to say, doctor is probably not going to be your thing.

McParadigm wrote:We couldn’t use the lag in cases to build up our capacity because the president is at the center of federal pandemic response planning. Whether you have any interest in the cause and effect of the president of the United States advancing conspiracies about COVID is irrelevant to whether or not it matters.

As the Trump administration races to buy hundreds of millions of syringes for what is likely to be an unprecedented COVID-19 immunization campaign, success depends heavily on two small medical supply companies with little track record of fulfilling government orders of that magnitude.

Retractable Technologies Inc., based in Little Elm, Texas, announced an $83.8-million government contract in May to provide an undisclosed number of syringes and needles for use with a COVID-19 vaccine. In dollar terms, the single order is double the company’s entire 2019 revenue, according to filings with the Securities and Exchange Commission.

Company officials recently warned of possible COVID-19-related supply disruptions due to the fact that 83% of Retractable’s products are made in China, but they also have told shareholders they are confident they can fill the large order.

A second order — for $27.4 million worth of syringes and needles, with an option to go up to $54 million — went to privately held Marathon Medical Corp., an Aurora, Colo.-based medical distribution company that has no factories of its own and acts largely as a middleman.

The company, which has 29 employees, had never been tasked with filling a federal contract larger than $3.1 million, according to a review of federal contract data.

Until last week, some industry experts had noted the absence of the nation’s leading syringe manufacturer, Becton, Dickinson and Co., or BD, from the government’s campaign. They worried that the administration might not be moving quickly enough to secure additional contracts, since the U.S. is already competing against other nations that are similarly ramping up for a vaccine.

Health and Human Services alleviated some of that concern last week with an additional $18-million contract for 50 million syringes from BD by December.

Vaccination could mean the U.S. would need up to 850 million syringes in 2021 to cover COVID-19 alone.

McParadigm wrote:

McParadigm wrote:We couldn’t use the lag in cases to build up our capacity because the president is at the center of federal pandemic response planning. Whether you have any interest in the cause and effect of the president of the United States advancing conspiracies about COVID is irrelevant to whether or not it matters.

As the Trump administration races to buy hundreds of millions of syringes for what is likely to be an unprecedented COVID-19 immunization campaign, success depends heavily on two small medical supply companies with little track record of fulfilling government orders of that magnitude.

Retractable Technologies Inc., based in Little Elm, Texas, announced an $83.8-million government contract in May to provide an undisclosed number of syringes and needles for use with a COVID-19 vaccine. In dollar terms, the single order is double the company’s entire 2019 revenue, according to filings with the Securities and Exchange Commission.

Company officials recently warned of possible COVID-19-related supply disruptions due to the fact that 83% of Retractable’s products are made in China, but they also have told shareholders they are confident they can fill the large order.

A second order — for $27.4 million worth of syringes and needles, with an option to go up to $54 million — went to privately held Marathon Medical Corp., an Aurora, Colo.-based medical distribution company that has no factories of its own and acts largely as a middleman.

The company, which has 29 employees, had never been tasked with filling a federal contract larger than $3.1 million, according to a review of federal contract data.

Until last week, some industry experts had noted the absence of the nation’s leading syringe manufacturer, Becton, Dickinson and Co., or BD, from the government’s campaign. They worried that the administration might not be moving quickly enough to secure additional contracts, since the U.S. is already competing against other nations that are similarly ramping up for a vaccine.

Health and Human Services alleviated some of that concern last week with an additional $18-million contract for 50 million syringes from BD by December.

Vaccination could mean the U.S. would need up to 850 million syringes in 2021 to cover COVID-19 alone.